Lexaria Bioscience Cash Flow Statement (2010-2026) | LEXX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Oct2010 Jan2011 Apr2011 Jul2011 Oct2011 Jan2012 Apr2012 Jul2012 Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Jan2014 Apr2014 Jul2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Feb2022 May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025 Nov2025 Feb2026
Operating Activities
Net Income (Quarter)
-2.00M-1.45M-2.42M-0.75M-1.70M-1.32M-2.40M-1.11M-1.13M-0.67M-1.74M-2.20M-2.69M-2.75M-3.75M-2.69M-1.58M-1.45M
Depreciation and Depletion (Quarter)
0.03M0.03M0.03M0.03M0.02M
Share-based Compensation (Quarter)
0.41M0.41M0.11M-0.24M0.07M0.01M0.08M0.01M0.05M0.34M0.10M0.10M0.17M0.47M0.12M0.07M0.07M
Cash from Discontinued Operations (Quarter)
Gains from Investment Securities (Quarter)
0.01M0.01M0.01M0.01M0.04M0.47M0.05M0.13M0.09M0.09M0.83M0.01M0.01M0.14M0.59M0.01M1.48M1.48M
Asset Writedowns and Impairment (Quarter)
0.01M-0.03M
Non-cash Items (Quarter)
0.05M0.45M0.46M0.00M0.05M0.40M0.98M0.97M0.11M0.04M1.28M206.000.03M
Cash from Operations (Quarter)
-1.16M-1.11M-1.17M-1.28M-1.26M-1.18M-1.25M-1.23M-1.79M-1.62M-1.18M-0.62M-1.27M-1.89M-2.73M-1.50M-3.58M-2.64M-0.98M-2.16M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
0.11M0.03M
Amortizatization of Intangibles (Quarter)
67.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Amortization of Deferred Charges (Quarter)
0.03M
Depreciation & Amortization (CF) (Quarter)
0.03M0.03M0.03M0.03M0.02M0.02M0.02M0.02M0.03M0.07M0.03M0.02M0.02M-0.06M0.03M0.00M-0.04M0.04M
Change in Working Capital
Change in Receivables (Quarter)
0.07M-0.19M0.12M0.05M-0.25M-0.05M0.08M-0.02M-0.09M0.03M0.41M-0.18M-0.15M-0.05M0.11M0.07M0.03M0.01M-0.28M-0.05M
Change in Inventory (Quarter)
-0.09M-0.02M-0.00M0.00M-0.01M0.01M-0.03M0.06M-0.08M
Change in Account Payables (Quarter)
-0.21M0.00M-0.01M
Change in Accured Expenses (Quarter)
0.03M-0.07M0.09M-0.07M0.04M-0.01M0.09M-0.05M0.83M-0.78M-0.14M-0.04M0.07M0.94M-0.80M1.52M-0.33M0.00M-0.04M-1.24M
Other Working Capital Changes (Quarter)
0.03M-0.03M-0.08M0.08M0.16M-0.16M-0.32M0.57M-0.20M-0.05M-0.41M0.41M-0.03M-0.01M-0.74M0.41M0.33M1.000.01M
Investing Activities
Capital Expenditures (Quarter)
0.04M0.01M4.000.02M0.01M0.04M0.02M1.00-1.001.000.04M
Change in Intangibles (Quarter)
0.07M0.02M0.03M0.03M0.05M0.01M0.02M0.03M0.07M0.04M0.06M0.02M0.03M0.01M0.03M0.02M0.01M0.01M0.02M
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)
-0.07M-2.00-0.06M-0.03M-0.04M-0.05M-0.03M-0.03M-0.03M-0.07M-0.04M-0.06M-0.02M-0.07M-0.04M-0.03M-0.02M-0.16M-0.01M-0.05M
Financing Activities
Other financing activities (Quarter)
0.09M1.20M-0.30M0.17M
Cash from Financing Activities (Quarter)
-0.01M4.00M-0.01M-0.01M-0.01M-0.01M1.71M-0.12M1.82M3.45M5.04M4.35M0.01M1.69M3.47M3.04M
Additional items
Exchange Rate Effect (Quarter)
0.00M-0.02M-0.00M0.00M-0.00M-0.10M0.04M0.01M-0.01M0.02M
Change in Cash (Quarter)
-1.24M2.81M-1.24M-1.32M-1.31M-1.24M-1.28M-1.26M-0.11M-1.81M0.60M2.75M3.75M-1.96M1.58M-1.61M-1.88M-2.79M2.48M0.85M
Beginning Cash Balance (Quarter)
Free Cash Flow (Quarter)
-1.16M-1.11M-1.21M-1.28M-1.27M-1.18M-1.27M-1.24M-1.79M-1.62M-1.18M-0.62M-1.27M-1.93M-2.75M-1.50M-3.58M-2.64M-0.98M-2.20M
Net Cash Flow (Quarter)
-1.24M2.89M-1.24M-1.32M-1.31M-1.24M-1.28M-1.26M-0.11M-1.81M0.60M2.78M3.75M-1.96M1.58M-1.51M-1.91M-2.80M2.48M0.83M